Background: Standardized pain-intensity measurement across different tools would enable practitioners to have confidence in clinical decision making for pain management. Objectives: The purpose was to examine the degree of agreement among unidimensional pain scales and to determine the accuracy of the multidimensional pain scales in the diagnosis of severe pain. Methods: A secondary analysis was performed. The sample included a convenience sample of 480 cancer patients recruited from both the Internet and community settings. Cancer pain was measured using the Verbal Descriptor Scale (VDS), the visual analog scale (VAS), the Faces Pain Scale (FPS), the McGill Pain QuestionnaireYShort Form (MPQ-SF), and the Brief Pain InventoryYShort Form (BPI-SF). Data were analyzed using a multivariate
S tandardized pain-intensity measurement across different tools would enable practitioners to have confidence in clinical decision making for pain management. 1 A number of instruments are being used to measure intensity or severity of selfreported pain using a unidimensional approach. These methods include a visual analog scale (VAS), a Verbal Descriptor Scale (VDS), a Faces Pain Scale (FPS), and a numerical rating scale (NRS). In addition, multidimensional instruments have been developed and used to reflect the multidimensionality of the pain experience; these include the McGill Pain Questionnaire (MPQ) and the Brief Pain Inventory (BPI). Although these scales have been validated and were found reliable to measure pain, Jones et al 1 contend that these multiple scales have varying numbers of pain levels with different wordings for pain scores, making comparisons across multiple instruments difficult. They examined the equivalency of the 3 unidimensional pain scales (the VDS, NRS, and FPS) among nursing home residents and found 69.6% to 83.7% agreement rates between the instruments; this indicates highly correlated pain intensity measurement across all 3 instruments. However, the study also revealed that there was extensive variability in individual pain reporting, and nursing home residents tended to underrate pain intensity on the FPS. 1 Others examined the applicability of PainDetect, a self-report questionnaire used to screen neuropathic pain in patients with fibromyalgia. 2 They constructed a receiver operating characteristic (ROC) curve to determine cutoff points for PainDetect, and the ROC curve showed low specificity (0.53) with sensitivity of 0.79 and poor accuracy with the value of area under the ROC curve (AUC) of 0.69. This indicated that PainDetect is not useful as a screening tool for neuropathic pain. 3 There have been no studies on agreement among the pain scales or on the cutoff points of multiple pain scales in multiethnic groups of cancer patients. 3, 4 However, it has been suggested that patients' cultures and ethnicities influence variations in pain perception and expression. Thus, comparison across multiple unidimensional pain scales as well as information on the cutoff points of multidimensional pain scales among multiethnic groups would help to standardize pain ratings and to provide valuable information regarding applicability of the pain instruments to screen cancer pain in multicultural settings. 1, 2, 5 The purpose of this secondary analysis study was to examine the degree of agreement among various unidimensional pain scales (the VDS, VAS, and FPS) and to determine whether multiple pain instruments accurately represent the degree of self-reported cancer pain in a multiethnic group of cancer patients. In addition, this study aimed to determine the diagnostic accuracy for severe cancer pain including sensitivity and specificity of multidimensional pain scales (the MPQ-SF and BPI-SF) using reference criteria (criterion standard), which was produced by a combination of multiple unidimensional pain scales. Here, diagnostic accuracy indicates the ability of pain scales to discriminate severe pain among cancer patients. Diagnostic accuracy can be quantified in terms of sensitivity, specificity, positive likelihood ratio (LR+), and negative likelihood ratio. 6 n Methods Design This is a secondary analysis of the data from a cross-sectional study on gender and ethnic differences in cancer pain experience. This study was approved by the institutional review board of the university with which the authors are affiliated.
Sample and Setting
The sample included 480 cancer patients recruited from both the Internet (n = 204) and community (n = 276) settings using a convenience sampling method. The study recruited cancer patients from cancer clinics and cancer support groups in community settings across the United States and from cancer support groups on the Internet. Internet cancer support groups were identified through major Internet search engines (eg, Google, MSN, and Yahoo). Ten community consultants, identified through Internet searches, helped to recruit cancer patients in community settings. Inclusion criteria for research participants were cancer patients aged at least 18 years who could read and write English and whose self-reported racial/ethnic identity was Hispanic, non-Hispanic (NH) white, African American, or Asian. The original study identified that there were no statistically significant differences in psychometric properties between the Internet format and the pen-and-pencil format of the questionnaire (P 9 .05). 7 With an ! of .05 and an AUC of 0.725, a total of 57 participants would be needed for the ROC curve analysis. 8 Therefore, 480 patients in the original study were deemed sufficient for the analysis.
Instruments
The study instruments included questions on sociodemographic characteristics, self-reported health and disease status, and multiple instruments measuring self-reported cancer pain, and functional status of cancer patients. The questions on sociodemographic characteristics included age, gender, education, employment status, and race/ethnicity. The questions on disease status included those on cancer diagnosis and treatment (eg, site/type/stage of cancer, and use of pain medicine).
Self-reported cancer pain was measured using the VDS, the VAS, the Wong-Baker FPS, the MPQYShort Form (MPQ-SF), and the BPIYShort Form (BPI-SF). The VDS, which measures self-reported pain, has numerical values from 0 (no pain) to 5 (worst possible pain). The VAS measures pain intensity using a 10-cm horizontal line with word anchors at each end of the line (ie, no pain and worst pain possible), and the FPS consists of 6 faces that are assigned numerical values from 0 (a very happy smiling face) to 5 (a sad, tearful face). 9 These unidimensional instruments have been reported to be reliable and valid in multiple ethnic groups of cancer patients. 5, 10 In order to make comparison across multiple pain intensity scales, the VDS, VAS, and FPS were recategorized into no pain, mild, moderate, and severe pain based on previous studies. 1, 4, 11 The VDS rated pain as no pain, mild pain, moderate pain, severe pain, very severe pain, and worst possible pain. It was recategorized into no pain, mild pain, moderate pain, and severe pain by combining 3 pain categories (severe pain, very severe pain, and worst possible pain) into a single new severe pain category. 1, 11 The FPS was recategorized based on previous studies, 1, 12 and accordingly, no hurt (smiling face) was recategorized as no pain, hurts a little bit and hurts a little more were recategorized as mild pain, hurts even more was recategorized as moderate pain, and hurts a whole lot and hurts worst (tearful face) were recategorized as severe pain. The process of categorizing VAS was provided in the results section.
Use of standardized pain categories (no pain, mild, moderate, and severe pain) is critically important. 1 Researchers argued that multiple pain scales measure pain using varying numbers and different wordings of pain intensity scores, and therefore a comparison across pain scales is problematic. 1 A standardized metric for pain intensity would improve clinical decision making and enhance communication about pain among clinicians, and between the clinician and patient, and the investigators could compare pain evaluation outcomes across groups that have used different scales with confidence. 1 The MPQ-SF was used as a multidimensional pain assessment scale with 3 components: pain rating index (PRI), VAS, and present pain intensity. 13 Only the PRI part was used in this study. The PRI consists of 15 descriptors including 11 sensory and 4 affective pain intensity scales and was measured with a 4-point Likert scale (0 = none, 1 = mild, 2 = moderate, or 3 = severe). Total scores were calculated by adding up all 15 items in the PRI part of the MPQ-SF for analysis in the current study (range, 0Y45). The Cronbach's ! of the MPQ-SF was .94 in this sample. 7 The BPI-SF consists of 15 items to measure sensory, affective, physiologic, and behavioral pain. 14 Among the 15 items in the BPI-SF, only the 4 items in the pain intensity part (pain now, and its worst, least, and average during the past week) were used in the analysis, because a previous study suggested that 4 pain intensity items of the BPI can be combined to give an index of pain severity. 15 Thus, total BPI-SF scores were produced by adding up the 4 items (range, 0Y40). These items were measured with 0-to 10-point NRSs (0 = no pain or does not interfere and 10 = pain as bad as you can imagine or completely interferes). The Cronbach's ! of the BPI-SF was .96 in this sample. 7 The Functional Assessment of Cancer Therapy ScaleYGeneral (FACT-G) was used to measure functional status of patients. The FACT-G scores were used to determine optimal cutoff points of mild, moderate, and severe pain for VAS, in order to enable comparisons across multiple unidimensional pain scales. The FACT-G consists of 33 items in 5 domains: physical, social and family, emotional, and functional well-being, and relationship with the physician. 16 Among the 33 items, 28 items were measured with a 5-point Likert scale (0 = not at all, and 4 = very much), whereas the other 5 items were measured with a linear analogue scale from 0 (not at all) to 10 (very much so). The total FACT-G scores were determined by adding up the 33 item scores (range, 0Y162). The Cronbach's ! was .70 in this sample. 7 Reliability and validity of the multidimensional pain scales use in multiethnic groups were verified in previous studies for the MPQ-SF, 17, 18 the BPI-SF, 18, 19 and the FACT-G. 11Y20
n Procedures
In the original study, a Web-based survey was conducted via a project Web site developed by the research team members of the original study. 7 Potential participants, recruited through Internet cancer support groups, visited the study Web site and completed the questionnaire after agreement through an informed consent online. Pen-and-pencil questionnaires were mailed to community consultants, who distributed the questionnaire to cancer patients in person. Community consultants collected completed questionnaires with signed informed consent and then mailed them to the research team. Data collections in both the Internet and community settings relied on participants' self-reports. Community consultants were encouraged to recruit ethnic minority cancer patients so that the study could include similar numbers across ethnic groups. However, ethnic differences in types of cancer pain and symptoms accompanying cancer pain were beyond the scope of the current study, which were previously reported using the same data set. 7 On average, the questionnaire took 30 to 40 minutes to complete, either on the Internet or using pen and pencil. Data were collected in 2006. The data from both Internet and pen-and-pencil surveys were included for this secondary analysis.
Data Analysis
The Statistical Package for the Social Sciences 20.0 for Windows was used for data analysis (SPSS, Inc, an IBM Company, Chicago, Illinois). The data on background characteristics and disease characteristics were analyzed using descriptive statistics such as means, SDs, frequencies, and percentages. Cross-tabulations were formulated to assess the degree of agreement between 2 different single-item pain scales (the VDS vs VAS, the VDS vs FPS, and the VAS vs FPS).
A multivariate analysis of variance (MANOVA) was conducted to determine cutoff points for the VAS. The criteria used to determine the optimal boundaries were pain categories that yielded a larger F ratio for the between-subject effect on the 5 dimensions of FACT-G (physical, social/family, emotional, and functional well-being, and relationship with the physician).Those criteria yielded fairly consistent results across the 4 ethnic groups (small F ratio) on the 3 tests (Pillai trace, Hotelling trace, and Wilks 1). These were used to determine the criterion ratio (the F ratio for main effects of pain category divided by the F ratio for the interaction term [pain category Â ethnic group]). 4 To determine cutoff points of mild, moderate, and severe pain for NRS, Serlin et al 4 used 7 items of interference with life in the BPI as dependent variables in the MANOVA. They assumed that mild, moderate, and severe pain would differently impact multiple functions of cancer patients. Accordingly, to determine cutoff points for VAS, the current study used multiple dimensions of FACT-G as dependent variables in the MANOVA.
The ROC curve was constructed to evaluate the accuracy of the multidimensional pain scales in the diagnosis of severe pain. A previous study reported that since pain is subjective in nature, patients' self-reports are the criterion standard for pain assessment. 1 Thus, the criterion standard for severe pain was produced by combining VDS and VAS, which showed the highest agreement rate between the unidimensional scales in the current study. Using the ROC curve, the AUC scores were examined to evaluate the diagnostic accuracy, then sensitivity and specificity scores were
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Cancer Nursing TM , Vol. 38, No. 4, 2015 n 307 produced to determine cutoff values for individual instruments. The ROC curve is used in medicine to express the diagnostic accuracy of clinical tests, which are graphical plots of sensitivity (y axis) and 1 j specificity (x axis), and the AUC is the gross AUC, which is used as a global indicator of diagnostic performance. 21 The AUC between 0.90 and 1.0 indicates high accuracy, that between 0.70 and 0.90 indicates moderate accuracy, and that between 0.50 and 0.70 indicates low accuracy. 22 Null hypotheses of no differences were rejected if P G .05.
n Results 4 With the VAS, Hirschfeld and Zernikow 3 identified 7 pairs of combinations for potential cutoff points of mild, moderate, and severe pain (40Y70, 35Y70, 45Y70, 35Y60, 40Y75, 30Y60, and 30Y70) that were found in more than 5% of the samples. Using these 7 pairs of potential cutoff points, 7 separate MANOVAs were conducted. Ethnic group (Hispanic, NH whites, African Americans, and Asians) and pain severity with 4 levels (no, mild, moderate, and severe pain) were entered as between-subject factors, whereas 5 dimensions of FACT-G were entered as dependent variables. The cutoff point of the 35Y70 pair had the highest criterion ratio in all of the 3 tests (Pillai trace = 17.44, Hotelling trace = 27.37, and Wilks 1 = 22.17). Thus, the optimal cutoff points for the VAS were set at 0 (no pain), 1 to 35 (mild), 36 to 70 (moderate), and 71 to 100 (severe) in the current study. Using the recategorized VDS and FPS, the agreement between the VDS and FPS was 71.88% (340/473) with a Cohen . = 0.624. With the cutoff points of 35 to 70 for the VAS, the agreement between the VDS and VAS was 77.25% (326/422) with a Cohen . = 0.695, whereas the agreement between the VAS and FPS was 71.60% (300/419) with a Cohen . = 0.617.
General and Clinical Characteristics of the Patients
Cohen . values between 0.61 and 0.80 indicate substantial agreement between the 2 scales. 23 Existence of cancer pain, at least mild pain, was reported in 67.8% (VAS), 71.4% (VDS), and 74.9% (FPS) of the participants ( Table 2 ).
Accuracy of the MPQ-SF and BPI-SF in the Diagnosis of Severe Pain
In the ROC curve analysis, combined scores of the VDS and VAS were used as the criterion standard for diagnostic criteria of severe pain because the highest agreement rate was found between the VDS and VAS than between the VDS and FPS, and the VAS and FPS. Those who consistently responded in the same pain category (no pain-no pain, mild-mild, moderate-moderate, and severe-severe pain) were included in the ROC curve (n = 326). The results indicated that the MPQ-SF and BPI-SF showed high accuracy in diagnosis of severe pain with AUC values greater than 0.9 (Figure; Table 3 ).
Sensitivity and Specificity of the MPQ-SF and BPI-SF for Severe Pain
The optimal cutoff point for severe pain was greater than 8 for the MPQ-SF according to the ROC curve, which resulted in 93% sensitivity and 82% specificity, and the optimal cutoff point was greater than 14 for the BPI-SF with 90% and 80% of sensitivity and specificity, respectively. The LR+ ranged from 4.41 (the BPI-SF) to 5.03 (the MPQ-SF), indicating that the results for the scales were associated with the presence of severe pain, whereas the negative likelihood ratio (LRj) ranged from 0.09 (the MPQ-SF) to 0.12 (the BPI-SF), meaning that the results were associated with the absence of severe pain (Table 4) .
n Discussion
The current analysis sought to examine agreement between unidimensional pain scales (the VDS, VAS, and FPS) and to evaluate the accuracy of multidimensional pain scales (MPQ-SF and BPI-SF) in the diagnosis of severe pain. The study results illustrated substantial agreement between the VDS and VAS (77.25%), between the VDS and FPS (71.88%), and between the VAS and FPS (71.60%).
In the ROC curve, the MPQ-SF and BPI-SF yielded high accuracy in the diagnosis of severe pain. This analysis is unique because the data came from 4 major ethnic groups in a comparable sample size in each ethnic group. The results of this study will provide valuable information regarding multiple pain scales that could be utilized with cancer patients from multiethnic groups. There have been no studies on the cutoff points of multiple pain scales in a multiethnic group of cancer patients. 3, 4 The result of the present study was similar to the previous study, which reported 68.9% agreement between the VDS and FPS measured with nursing home residents. 1 They concluded that patients underrated higher intensity pain on the FPS. Similarly, cancer patients underestimated pain using the FPS when compared with the VDS in our study. For example, 25.6% of those in the mild pain category of the FPS (hurts a little) belonged to the moderate pain category in the VDS, and 30.4% of those in the moderate pain category on the FPS (hurts even more) belonged to the severe pain category of the VDS. Others also reported that there is a weak correlation between FPS and other pain scales. 10 Therefore, researchers should be aware of the tendency of underestimated pain using the FPS and be cautious in the interpretation of pain measured with the FPS. In our study, 19.4% to 23.2% of the cancer patients had severe pain measured with the VDS, VAS, and FPS, whereas a previous study reported that among cancer patients, 45.6% had severe pain, 24 and others reported that 26.2% had severe pain. 25 Previous researchers examined cancer pain targeting metastatic cancer patients; thus, they may have reported a higher proportion of severe pain than the present study. 24 Others assessed cancer pain targeting all cancer patients admitted to the hospital; thus, they might have more severe pain compared with cancer patients dwelling in the community in our study. 25 Accurate pain assessment is a prerequisite for quality pain control; thus, by using multiple tools, practitioners could gain confidence in clinical decision making, whereas standardized cutoff points could enable researchers to compare across different groups. 26 The current study found that there were wide variations in VAS pain scores within the same pain category of VDS: mild pain = 0 to 90, moderate pain = 0 to 95, and severe pain = 0 to 100, which is similar to a previous study. 1 Jones et al 1 argued that individual interpretations of faces, numbers, and verbal descriptors differ significantly; thus, extensive variability existed.
Former researchers suggested 36 to 60 as optimal cutoff points for mild, moderate, and severe pain for VAS using the same method as in the current study. 3 To set up cutoff points, Serlin et al 4 included the degree of interferences in multiple aspects of life (enjoyment of life, activity, walking, mood, sleep, work, and relations with others) as dependent variables in the MANOVA. Other researchers used the VDS as criteria to determine cutoff points for the VAS and contended that a VAS score in excess of 30 mm could be recorded at least as moderate; over that point, 85% of the patients reported moderate pain measured with the VDS. 27 If we used a different method to determine cutoff points for the VAS, different cutoff points would be produced and, in turn, would have yielded different results in agreement rates between the pain scales. Similarly, if we used different dependent variables other than the FACT-G in the MANOVA to determine cutoff points, we might have produced different cutoff points. Thus, researchers and practitioners need to be aware that cutoff points for the VAS would be varied by the method used to determine cutoffs, as well as by the health condition and population under study. Although the VAS is regarded as one of the best methods of evaluating pain intensity with high sensitivity, 28 it has practical issues including wide variations in VAS scores within the same pain intensity category when examined with the VDS, difficulty in set up cutoff points, and the varying cutoff points provided by different researchers. 7, 27, 29 The VDS and categorized VAS, however, were combined to produce a new pain category in our study that was used as the criterion standard to test the diagnostic accuracy of the multidimensional scales (MPQ-SF and BPI-SF). Also, those who consistently responded to the same pain categories across the 2 scales were included in the ROC curve. The current study found that the MPQ-SF and the BPI-SF showed high accuracy (AUC at least 0.90) in the diagnosis of severe pain, indicating that the MPQ-SF and the BPI-SF could be used as valid pain screening tools with precision. This study also suggested optimal cutoff points for these 2 multidimensional pain scales. Vallerand 30 suggested including 1 or more multidimensional instruments that assess pain, when 2 or more dimensions of the pain experience are to be measured. The MPQ provides a precise and comprehensive measure of pain characters, whereas the BPI provides a holistic picture of how pain affects patients' lives. 30 Thus, these multidimensional instruments could be used selectively according to the purpose of pain assessment.
In the present study, the cutoff point was greater than 8 for the MPQ-SF (sensitivity = 0.93, and specificity = 0.82) and greater than 14 for the BPI-SF (sensitivity = 0.90, and specificity = 0.80) that distinguish between moderate and severe pain. Based on the ROC curve coordinates of MPQ-SF, if we want to increase specificity by 0.90, sensitivity would be decreased to 0.81 with a cutoff point of greater than 13. Thus, practitioners should consider weighing whether sensitivity or specificity holds more value in determining cancer pain categories. Researchers have contended that likelihood ratios are more useful than sensitivity and specificity for instrument accuracy. 6 The LR+ of 5.03 for the MPQ-SF indicates that those who have severe pain are 5.03 times more likely to have positive test results compared with those without severe pain, and the present study revealed that according to LR+, the MPQ-SF is more accurate compared with the BPI-SF (LR+ = 4.41).
Limitations
A limitation of the present study is that the study included only those who speak English. If we evaluated pain using other languages, different verbal descriptors and interpretations would yield different pain intensity scores and cutoff points. Another limitation may be that 37.3% of the patients used pain medication, and we could not control the effects of pain medication on self-reported pain. Similarly, we did not consider cancer site, cancer stage, duration of cancer diagnosis, and previous medical treatments in the measure of cancer pain, all of which may influence pain intensity, thus limiting the study results.
Implications for Practice
The current study evaluated consistency and diagnostic accuracy of multiple pain screening tools and found substantial agreement between the VDS and VAS, the VDS and FPS, and the VAS and FPS. The study also revealed high accuracy of the MPQ-SF and the BPI-SF in the diagnosis of severe cancer pain. Because of the subjective nature of pain, 1 issues remain in properly quantifying pain intensity using self-reported measures. 31 Previous researchers suggested that because cancer pain has a multidimensional nature, cancer pain could thus be best evaluated by combining multidimensional screening tools with pain intensity rating scales such as the VAS. 31 The use of 1 or more pain screening tools whose diagnostic accuracy and consistency have been validated will help classify pain effectively and subsequently promote optimal pain control in multiethnic groups of cancer patients. 4 Further research is needed to examine consistency and diagnostic accuracy of unidimensional and multidimensional scales in assessing pain targeting other than that in cancer patients, such as arthritis pain and neuropathic pain.
